ES2540751T3 - Composición para mejorar la función sexual masculina que contiene extracto de baya de ginseng - Google Patents

Composición para mejorar la función sexual masculina que contiene extracto de baya de ginseng Download PDF

Info

Publication number
ES2540751T3
ES2540751T3 ES13189406.5T ES13189406T ES2540751T3 ES 2540751 T3 ES2540751 T3 ES 2540751T3 ES 13189406 T ES13189406 T ES 13189406T ES 2540751 T3 ES2540751 T3 ES 2540751T3
Authority
ES
Spain
Prior art keywords
composition
sexual function
male sexual
berry extract
ginseng berry
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES13189406.5T
Other languages
English (en)
Inventor
Chan-Woong Park
Myeong Hoon Yeom
Nam Hoon Cho
Sang Jun Lee
Sang Min Lee
Jin Young Lee
Hee Yong Jeon
Young-Myeong Kim
Chun-Ki Kim
Young Deuk Choi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amorepacific Corp
Original Assignee
Amorepacific Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020080043488A external-priority patent/KR101030608B1/ko
Application filed by Amorepacific Corp filed Critical Amorepacific Corp
Application granted granted Critical
Publication of ES2540751T3 publication Critical patent/ES2540751T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Endocrinology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • Vascular Medicine (AREA)
  • Rheumatology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Pregnancy & Childbirth (AREA)
  • Toxicology (AREA)
  • Physical Education & Sports Medicine (AREA)

Abstract

Una composición que comprende extracto de bayas de Panax ginseng C.A. Meyer como principio activo para su uso terapéutico en la mejora de la función sexual masculina.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10
imagen11
imagen12
imagen13
imagen14
imagen15

Claims (1)

  1. imagen1
ES13189406.5T 2007-05-28 2008-05-28 Composición para mejorar la función sexual masculina que contiene extracto de baya de ginseng Active ES2540751T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR1020070051593A KR20080104600A (ko) 2007-05-28 2007-05-28 인삼 열매 추출물을 함유하는 혈행촉진, 혈관신생촉진, 및허혈성 심질환 치료용 조성물
KR20070051593 2007-05-28
KR20080043488 2008-05-09
KR1020080043488A KR101030608B1 (ko) 2007-05-11 2008-05-09 인삼열매 추출물을 함유하는 남성 성기능 개선용 조성물

Publications (1)

Publication Number Publication Date
ES2540751T3 true ES2540751T3 (es) 2015-07-13

Family

ID=40366190

Family Applications (1)

Application Number Title Priority Date Filing Date
ES13189406.5T Active ES2540751T3 (es) 2007-05-28 2008-05-28 Composición para mejorar la función sexual masculina que contiene extracto de baya de ginseng

Country Status (8)

Country Link
US (1) US20100297270A1 (es)
EP (3) EP2689784B1 (es)
JP (8) JP2010528108A (es)
KR (1) KR20080104600A (es)
CN (4) CN101720225A (es)
ES (1) ES2540751T3 (es)
HK (2) HK1211222A1 (es)
WO (1) WO2008147111A2 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101098581B1 (ko) 2009-01-09 2011-12-26 서울대학교산학협력단 Ａｂｈ 항원을 이용한 염증질환 개선용 조성물
JP5621204B2 (ja) * 2009-03-31 2014-11-12 日油株式会社 血管老化予防剤
CN106511415A (zh) 2010-05-24 2017-03-22 Nse产品公司 用于抵抗衰老作用的口服制剂
KR101829330B1 (ko) * 2011-04-13 2018-02-20 (주)아모레퍼시픽 염증성 피부 노화 억제 물질 스크리닝 방법
KR20130046115A (ko) * 2011-10-27 2013-05-07 (주)아모레퍼시픽 시링가레시놀을 포함하는 혈관 노화 억제용 조성물
KR102016078B1 (ko) * 2012-11-30 2019-08-30 (주)아모레퍼시픽 심장 질환 예방 또는 치료용 조성물
EP2982377B1 (en) * 2013-04-02 2023-06-07 Amorepacific Corporation Ginseng berry extract for use in alleviating menopausal symptoms
KR102200012B1 (ko) * 2013-04-02 2021-01-08 (주)아모레퍼시픽 인삼열매 추출물을 포함하는 뇌 활성화 조성물
KR102249706B1 (ko) * 2013-04-03 2021-05-10 (주)아모레퍼시픽 인삼열매 추출물을 포함하는 수명 연장용 조성물
KR102262306B1 (ko) * 2013-07-04 2021-06-09 (주)아모레퍼시픽 월경 전기 증후군 및 월경통 완화의 기능을 갖는 조성물
CN104147250A (zh) * 2014-08-19 2014-11-19 李有花 缓解滴注液外渗肿胀的海绵及制备方法
CN104983616B (zh) * 2015-06-26 2018-09-25 东方福尚福养生有限公司 一种人体润滑液及其制备方法
JP2017042144A (ja) * 2015-08-28 2017-03-02 株式会社エレメンツ 経口組成物
KR102451839B1 (ko) * 2015-10-30 2022-10-11 (주)아모레퍼시픽 진세노사이드를 유효성분으로 함유하는 화장료 조성물
CN105559086A (zh) * 2015-12-31 2016-05-11 吉林紫鑫药业股份有限公司 人参果颗粒及其生产方法
JP6230638B2 (ja) * 2016-02-12 2017-11-15 株式会社らいむ 神経伸長促進剤、内服剤、培地用添加剤、細胞希釈液用添加剤、培地および細胞希釈液
EP3415586B1 (en) 2016-02-12 2022-11-30 Laimu Corporation Wound treatment agent and method for producing same
US12440465B2 (en) 2016-08-31 2025-10-14 Nse Products, Inc. Nutritional compositions and associated methods
KR102371418B1 (ko) * 2017-05-19 2022-03-08 (주)아모레퍼시픽 프로토파낙사트리올을 포함하는 피부 미백용 조성물
JP7016107B2 (ja) * 2017-06-07 2022-02-21 国立大学法人 鹿児島大学 血管内皮細胞の一酸化窒素産生を亢進する物質のスクリーニング方法
KR102056338B1 (ko) * 2019-08-09 2019-12-16 주식회사 에브릿 홍삼 진세노사이드와 미생물 마늘발효에서 유래된 글루타치온 성분이 함유된 혈행개선효과를 가지는 건강기능성 조성물
KR102842908B1 (ko) * 2019-09-27 2025-08-07 (주)아모레퍼시픽 신규 진세노사이드를 포함하는 피부 탄력 개선용 조성물
CN112999167B (zh) * 2021-03-01 2023-05-02 安徽九华华源药业有限公司 人参子速释微丸及其制备方法
JP2024017587A (ja) * 2022-07-28 2024-02-08 株式会社日本薬業 Ｔｉｅ２活性化向上剤
CN116392516B (zh) * 2023-04-14 2024-04-05 延边大学 一种人参提取物在制备膜剂中的应用、人参口腔膜剂及其制备方法和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0789863A (ja) * 1993-09-24 1995-04-04 Morishita Roussel Kk ジンセノサイド−Ｒｅの単離精製法及び該化合物を主成分とする抗不整脈剤
JPH07267977A (ja) * 1994-03-31 1995-10-17 I T Bi S:Kk オタネ人参の果実エキスよりなる配糖体及びその製造方法並びにこれを用いた健康食品とその製造方法
US6007824A (en) * 1998-07-09 1999-12-28 Duckett; Melvin J. Natural composition and method for the treatment of sexual dysfunction
CN1092203C (zh) * 1998-07-22 2002-10-09 北京鑫利恒医药科技发展有限公司 人参皂甙Re的提取工艺及其新的药物用途
JP2000212080A (ja) * 1999-01-26 2000-08-02 Hiroshi Azuma 勃起機能不全改善剤
MY124001A (en) * 1999-04-23 2006-06-30 E Excel Int Dietary supplements containing dehydrated cactus fruit juice and ginseng berry juice
US6524626B2 (en) * 1999-04-23 2003-02-25 E Excel International, Inc. Ginseng berry topical products
US6444237B1 (en) * 2001-09-13 2002-09-03 Pamela A. Heleen Herbal composition for enhancing sexual response
EP1660107A4 (en) * 2003-08-18 2008-06-04 Yuyu Inc GINSENG PREPARATION USING VINEGAR AND MANUFACTURING METHOD THEREFOR
JP4272100B2 (ja) * 2004-04-01 2009-06-03 ポーラ化成工業株式会社 くすみを改善する化粧料
JP2005306806A (ja) * 2004-04-23 2005-11-04 Nikko Chemical Co Ltd コラーゲン合成促進剤及び抗老化用化粧料
CN100443497C (zh) * 2004-04-27 2008-12-17 吉林省宏久生物科技股份有限公司 人参果甙提取方法
CN102000098B (zh) * 2004-08-11 2015-08-12 中国医学科学院药物研究所 人参皂甙Rg1的用途
EP1895966A4 (en) * 2005-04-26 2010-01-20 Ko Boong Kyung PROCESS FOR EXTRACTION OF GINSENGNOSID RG2M; PHARMACEUTICAL COMPOSITION WITH GINSENGNOSID RG2, AND ITS USES
JP2016024987A (ja) * 2014-07-22 2016-02-08 トヨタ自動車株式会社 非水系二次電池

Also Published As

Publication number Publication date
JP2014129368A (ja) 2014-07-10
CN102488731A (zh) 2012-06-13
JP2014080445A (ja) 2014-05-08
CN102429940A (zh) 2012-05-02
WO2008147111A3 (en) 2009-02-05
EP2689784A1 (en) 2014-01-29
HK1215198A1 (zh) 2016-08-19
EP2703004A1 (en) 2014-03-05
JP2015157870A (ja) 2015-09-03
JP2014080444A (ja) 2014-05-08
EP2152281A4 (en) 2013-04-10
JP6258988B2 (ja) 2018-01-10
JP6514298B2 (ja) 2019-05-15
HK1211222A1 (en) 2016-05-20
JP2018027973A (ja) 2018-02-22
CN101720225A (zh) 2010-06-02
CN104688618A (zh) 2015-06-10
JP2016164145A (ja) 2016-09-08
EP2152281A2 (en) 2010-02-17
CN104958332A (zh) 2015-10-07
JP6174729B2 (ja) 2017-08-02
JP2016074731A (ja) 2016-05-12
WO2008147111A2 (en) 2008-12-04
JP6059294B2 (ja) 2017-01-11
JP5952322B2 (ja) 2016-07-13
EP2152281B1 (en) 2015-09-09
EP2703004B1 (en) 2015-05-06
US20100297270A1 (en) 2010-11-25
EP2689784B1 (en) 2015-04-01
JP2010528108A (ja) 2010-08-19
KR20080104600A (ko) 2008-12-03

Similar Documents

Publication Publication Date Title
ES2602986T3 (es) Nuevas composiciones cosméticas y/o farmacológicas y sus aplicaciones
ES2478264T3 (es) Glicerosomas y uso de estos en preparaciones farmacéuticas y cosméticas para aplicación tópica
ECSP11011278A (es) Composición farmacéutica que comprende derivados de glucopiranosil difenilmetano, forma farmacéutica de la misma, procedimiento para su preparación y usos de la misma para el control glucémico mejorado en un paciente.
CR20120605A (es) Formulación tópica para un inhibidor de jak
UY28862A1 (es) Nuevas composiciones farmaceuticas para el tratamiento de los trastornos sexuales ii
CL2008000442A1 (es) Composicion farmaceutica que comprende a un quitosano, un ingrediente activo cosmetico o farmaceutico, y un solvente volatil; y su uso para tratar psoriasis, micosis entre otras enfermedades.
BRPI0618239A8 (pt) uso de flibanserina para o tratamento de distúrbios de desejo sexual pré-menopáusicos
AR047928A1 (es) Derivados de tetrahidropiridoindol
AR106702A2 (es) Uso de un anticuerpo antagonista anti-ngf para la preparación de un medicamento
BR112013000537A2 (pt) composição aquosa contendo bromexina
AR087208A2 (es) FORMA CRISTALINA DE 1-CLORO-4-(b-D-GLUCOPIRANOS-1-IL)-2-[4-((S)-TETRAHIDROFURAN-3-ILOXI)-BENCIL]-BENCENO, UN METODO PARA SU PREPARACION Y EL USO DEL MISMO PARA PREPARAR MEDICAMENTOS
CU20140068A7 (es) Triazolopiridinas sustituidas
MX345697B (es) Formulaciones de rifaximina y usos de las mismas.
CU20120171A7 (es) Triazolopiridinas sustituidas
DOP2007000043A (es) Derivados de cromanol sustituidos y su uso
CL2011002675A1 (es) Uso de compuestos derivados de nitrato o sulfato de 9-purin-9-il-3,4-dihidroxitetrahidrofuran-2-il-metilo para reducir la presion intraocular ; composicion farmaceutica oftalmica que comprende los compuestos; y formulacion oftalmica de uso topico que los comprende.
MX2010000266A (es) Un método para disminuir los síntomas del consumo de alcohol.
ECSP088889A (es) Forma nueva de administración de racecadotril
CL2013000735A1 (es) Uso de una composicion que comprende compuestos derivados de 1-h-imidazol-4-il sustituido para el tratamiento de enfermedades y condiciones de la piel, tales como rosacea, daño solar cronico, psoriasis, entre otras; kit farmaceutico.
UA106636C2 (uk) Морфолінотіазоли як позитивні алостеричні модулятори альфа 7
NI201000189A (es) Formulación de medicamento sólido con liberación retardadas.
ES2552654T3 (es) Uso de LCAT para tratar la anemia y la disfunción de los glóbulos rojos
CL2012003715A1 (es) Composicion fungicida sinergica de amplio espectro adecuada para su uso en la conservacion de un producto de madera encolada que comprende triadimefon y ciproconazol; método para la conservación de un producto de madera encolado.
ES2487496T3 (es) Agente para aliviar el síndrome metabólico
UY31758A (es) Forma cristalina anhidra de maleato de orvepitant